Medpage Today on MSN19h
Pfizer to Discontinue Its Hemophilia B Gene TherapyLess than a year after approval, Pfizer said it plans to discontinue its hemophilia B gene therapy fidanacogene elaparvovec ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback